Skip to content

Effects of exercise intensity on non-motor symptoms in early Parkinson’s disease: randomized, controlled, single-blinded, pilot study

Effects of exercise intensity on non-motor symptoms in early Parkinson’s disease: randomized, controlled, single-blinded, pilot study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CRIS
Registry ID
KCT0007130
Enrollment
33
Registered
2022-03-30
Start date
2022-03-17
Completion date
Unknown
Last updated
2023-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Behavioral : Patients enrolled in this study will be assigned to a high-intensity interval training group, moderate-intensity continuous training group, or control group. The high-intensity interval t

Sponsors

Inha University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients who were diagnosed with Parkinson's disease based on the UK Parkinson's Disease Society Brain Bank Diagnostic Criteria 2) Patients who were aged between 50 and 80 3) Patients with Hoehn and Yahr stage 1 or 2 4) Patients with the disease duration of less than 5 years 5) Patients who had a score = 1 in the MDS-UPDRS part 1 6) Patients who did less than the recommended aerobic exercise proposed by the American College of Sports Medicine (ACSM) (ex. vigorous exercise done <3 times per week, 20 min per session; or moderate exercise done <5 times per week, 30 min per session) 7) Patients who were on stable dopaminergic pharmacotherapy over more than 3 months

Exclusion criteria

Exclusion criteria: 1) Patients with neurological, orthopedic, or cardiac comorbidities that make them unfit to do aerobic exercise 2) Patients who were unable to complete questionnaires due to cognitive impairment 3) Patients on antipsychotics 4) Patients who have symptoms or signs suggesting atypical or secondary parkinsonism (ex. cerebellar signs, supranuclear gaze palsy, apraxia, prominent autonomic failure, or other cortical signs; multiple strokes with stepwise progression of symptoms) 5) Patients who were unavailable for more than 10% of the study period

Design outcomes

Primary

MeasureTime frame
Change in scores of the Non-Motor Symptoms Scale

Secondary

MeasureTime frame
Change in scores of the Montreal Cognitive Assessment;Change in scores of the Beck Depression Inventory;Change in scores of the Apathy Scale ;Change in scores of the Beck Anxiety Inventory;Change in scores of the Pittsburgh Sleep Quality Index;Change in scores of the Epworth Sleepiness Scale ;Change in scores of the RBD screening questionnaire ;Change in scores of the Scales for Outcomes in Parkinson's Disease - Autonomic ;Change in scores of the Parkinson Fatigue Scale ;Change in scores of the King's Parkinson's Disease Pain Scale ;Change in scores of the Parkinson's Disease Questionnaire-39;Change in scores of the MDS-UPDRS part 3 ;Change in maximal aerobic power (V?o2max)

Countries

Korea, Republic of

Contacts

Public ContactJi-Hee Kang

Inha University Hospital

kjbd42@naver.com+82-32-890-3864

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 10, 2026